Brevan Howard Capital Management’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $30.3M | Sell |
102,706
-9,244
| -8% | -$2.75M | 0.27% | 43 |
|
|
2025
Q4 | $30.6M | Buy |
111,950
+6,370
| +6% | +$1.73M | 0.33% | 45 |
|
|
2025
Q3 | $28.5M | Sell |
105,580
-69,136
| -40% | -$18.8M | 0.13% | 57 |
|
|
2025
Q2 | $48.2M | Buy |
174,716
+67,438
| +63% | +$18.3M | 0.28% | 35 |
|
|
2025
Q1 | $28.5M | Buy |
107,278
+3,069
| +3% | +$757K | 0.27% | 22 |
|
|
2024
Q4 | $24.2M | Sell |
104,209
-15,438
| -13% | -$3.55M | 0.16% | 27 |
|
|
2024
Q3 | $26.4M | Buy |
119,647
+7,352
| +7% | +$1.52M | 0.18% | 36 |
|
|
2024
Q2 | $22.1M | Buy |
112,295
+9,742
| +9% | +$2.01M | 0.2% | 28 |
|
|
2024
Q1 | $22.1M | Buy |
+102,553
| New | +$21.5M | 0.2% | 27 |
|
|
2023
Q4 | – | Sell |
-102,553
| Closed | -$20.5M | – | 1026 |
|
|
2023
Q3 | $20.5M | Hold |
102,553
| – | – | 0.26% | 20 |
|
|
2023
Q2 | $19M | Hold |
102,553
| – | – | 0.4% | 19 |
|
|
2023
Q1 | $19.6M | Hold |
102,553
| – | – | 0.52% | 21 |
|
|
2022
Q4 | $17.2M | Hold |
102,553
| – | – | 0.58% | 18 |
|
|
2022
Q3 | $18.2M | Hold |
102,553
| – | – | 0.66% | 14 |
|
|
2022
Q2 | $21M | Hold |
102,553
| – | – | 0.86% | 15 |
|
|
2022
Q1 | $24.4M | Hold |
102,553
| – | – | 1.3% | 8 |
|
|
2021
Q4 | $23.4M | Hold |
102,553
| – | – | 16.98% | 2 |
|
|
2021
Q3 | $19.8M | Hold |
102,553
| – | – | 2.58% | 10 |
|
|
2021
Q2 | $21.8M | Hold |
102,553
| – | – | 5.98% | 7 |
|
|
2021
Q1 | $20.9M | Hold |
102,553
| – | – | 3.08% | 13 |
|
|
2020
Q4 | $18.7M | Buy |
+102,553
| New | +$17.4M | 3.74% | 8 |
|
|
2017
Q3 | $13.9M | Hold |
102,553
| – | – | 32.01% | 1 |
|
|
2017
Q2 | $12.8M | Hold |
102,553
| – | – | 65.12% | 1 |
|
|
2017
Q1 | $12.2M | Hold |
102,553
| – | – | 59.41% | 1 |
|
|
2016
Q4 | $11.8M | Hold |
102,553
| – | – | 34.94% | 2 |
|
|
2016
Q3 | $10.7M | Hold |
102,553
| – | – | 0.91% | 4 |
|
|
2016
Q2 | $9.99M | Hold |
102,553
| – | – | 1.09% | 4 |
|
|
2016
Q1 | $9.85M | Hold |
102,553
| – | – | 0.78% | 9 |
|
|
2015
Q4 | $9.29M | Hold |
102,553
| – | – | 4.69% | 6 |
|
|
2015
Q3 | $9.51M | Hold |
102,553
| – | – | 4.79% | 9 |
|
|
2015
Q2 | $9.54M | Hold |
102,553
| – | – | 2.94% | 17 |
|
|
2015
Q1 | $9.71M | Hold |
102,553
| – | – | 3.51% | 9 |
|
|
2014
Q4 | $9.09M | Hold |
102,553
| – | – | 5.04% | 5 |
|
|
2014
Q3 | $8.2M | Hold |
102,553
| – | – | 2.85% | 10 |
|
|
2014
Q2 | $7.28M | Hold |
102,553
| – | – | 3.37% | 9 |
|
|
2014
Q1 | $7.59M | Hold |
102,553
| – | – | 3.66% | 9 |
|
|
2013
Q4 | $8.05M | Hold |
102,553
| – | – | 2.8% | 11 |
|
|
2013
Q3 | $7.58M | Hold |
102,553
| – | – | 3.54% | 11 |
|
|
2013
Q2 | $7.79M | Buy |
+102,553
| New | +$6.73M | 1.36% | 10 |
|
Other funds holding CME
VCM
VPM
Brevan Howard Capital Management's CME Position: Q1 2026 in Review
Brevan Howard Capital Management reduced its CME Group (CME) stake by 8.3% in Q1 2026, selling an estimated $2.75M and leaving 102,706 shares worth $30.3M. The position accounts for 0.27% of the portfolio, ranked #43.
Brevan Howard Capital Management first reported a position in CME in Q2 2013 and has held it in 39 quarters since. The position peaked at $48.2M in Q2 2025. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.
- Brevan Howard Capital Management held 102,706 shares of CME Group worth $30.3M as of Q1 2026.
- Brevan Howard Capital Management sold 9,244 CME Group shares in Q1 2026, an estimated $2.75M.
- CME Group made up 0.27% of Brevan Howard Capital Management's portfolio in Q1 2026, its #43 holding.
- Brevan Howard Capital Management first reported a position in CME Group in Q2 2013 and has held it in 39 quarters since.
- Brevan Howard Capital Management's CME Group position peaked at $48.2M in Q2 2025.
- 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.
Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.